Detalhe da pesquisa
1.
Hypomethylating agents are associated with high rates of hematologic toxicity in patients with secondary myeloid neoplasms developing after acquired aplastic anemia.
Haematologica
; 2024 Apr 18.
Artigo
Inglês
| MEDLINE | ID: mdl-38634143
2.
Clinical outcomes of hypomethylating agents plus Venetoclax as frontline treatment in patients 75 years and older with acute myeloid leukemia: Real-world data from eight US academic centers.
Am J Hematol
; 99(4): 606-614, 2024 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-38342997
3.
Real-world effectiveness of intensive chemotherapy with 7&3 versus venetoclax and hypomethylating agent in acute myeloid leukemia.
Am J Hematol
; 98(8): 1254-1264, 2023 08.
Artigo
Inglês
| MEDLINE | ID: mdl-37334852
4.
RAD21 mutations in acute myeloid leukemia.
Leuk Lymphoma
; : 1-7, 2024 Mar 20.
Artigo
Inglês
| MEDLINE | ID: mdl-38506144
5.
Targeting Menin and CD47 to Address Unmet Needs in Acute Myeloid Leukemia.
Cancers (Basel)
; 14(23)2022 Nov 29.
Artigo
Inglês
| MEDLINE | ID: mdl-36497385
6.
Real-world effectiveness of CPX-351 vs venetoclax and azacitidine in acute myeloid leukemia.
Blood Adv
; 6(13): 3997-4005, 2022 07 12.
Artigo
Inglês
| MEDLINE | ID: mdl-35507945
7.
Homeostatic control of B lymphocyte subsets.
Immunol Res
; 42(1-3): 75-83, 2008.
Artigo
Inglês
| MEDLINE | ID: mdl-18668213
8.
Refractory Lactic Acidosis in Small Cell Carcinoma of the Lung.
Case Rep Crit Care
; 2017: 6148350, 2017.
Artigo
Inglês
| MEDLINE | ID: mdl-28620552
9.
Local BLyS production by T follicular cells mediates retention of high affinity B cells during affinity maturation.
J Exp Med
; 211(1): 45-56, 2014 Jan 13.
Artigo
Inglês
| MEDLINE | ID: mdl-24367004